MedTrace Logo

Inhaled NO in IPF and COPD During 6 Minute Walk Test

NCT03873298 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-12-26

No results posted yet for this study

Summary

Our objective is to evaluate the influence of inhaled NO on the saturation and exercise capacity of patients with COPD and IPF. each participant will undergo two six minute walk tests, one with inhaled NO and the other with placebo.

Conditions

  • COPD
  • IPF
  • Inhaled Nitric Oxide
  • Six Minute Walk Test
  • Oxygen Saturation

Interventions

DRUG

Inhaled nitric oxide

Inhaled nitric oxide delivered through a pulsatile nitric oxide drug delivery system

Sponsors & Collaborators

  • Bellerophon

    collaborator INDUSTRY

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Mordechai Kramer, MD · Rabin Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-04
Primary Completion
2020-03-04
Completion
2020-09-01
FDA Drug
Yes

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03873298 on ClinicalTrials.gov